• Photo of nScrypt’s Sciperio and partners developing biomanufactured human blood

    Sciperio, the research arm of Florida-based nScrypt, has announced a joint project with several partners through which it will seek to develop on-demand human blood for future blood supply. The project will leverage nScypt’s microdispensing technology and will be undertaken in collaboration with The Uniformed Services University of the Health…

    Read More
  • Photo of CELLINK moves to NASDAQ Main Market Mid-Cap Index

    Less than five years since it was founded by a young team looking to produce and sell bioinks to the then very young bioprinting market, CELLINK is moving up to the NASDAQ Stockholm Main Market Mid-Cap In this short time span, the firm that originated in Gotheborg, Sweden expanded operations…

    Read More
  • Photo of Biogelx welcomes new CEO Alison Clayton

    Scotland-based biomaterials firm Biogelx has announced the appointment of a new CEO, Alison Clayton. Clayton will take over the leading position from Mitch Scanlan, who recently retired. The company has also announced the appointment of Margaret Temple to its board of directors as well as the completion of a successful…

    Read More
  • Photo of Allevi works with Corning Life Sciences to develop Matrigel matrix bioink

    After 30 years of discoveries and over 10,000 citations, Corning Matrigel matrix has cemented its place as a trusted ECM in biology labs worldwide. Biologists, tissue engineers, and industry giants alike rely on Matrigel matrix as a foundational biomaterial for diverse applications, from cancer and stem cell research to neurobiology.…

    Read More
  • Photo of Finland’s UPM launches non-animal derived GrowInk bioprinting materials

    Finland-based UPM Biofore, a company that works in the forest-based industry seeking sustainable solutions, is making inroads into the world of 3D printing with the development of new bioprinting materials through its UPM Biomedicals division. The materials, marketed under the GrowInk range, are non-animal derived hydrogels designed to support cell…

    Read More
  • Photo of Dimension Inx granted U.S. patent for 3D-Painting System

    Chicago-based biofabrication company Dimension Inx has been granted a U.S. patent covering its 3D-Painting System, a platform built for designing and manufacturing next-gen biomaterials for organ and tissue repair and regeneration. The company says the patent issuance strengthens its position on the market by showcasing the differentiation of its biomaterials…

    Read More
  • Photo of FELIXprinters announces commercial launch of new bioprinter

    Dutch 3D printer manufacturer FELIXprinters has just announced the commercial launch of the FELIX BIOprinter. The bioprinter, which was unveiled at Formnext 2019 in Frankfurt, is now ready for its market release. The company says it is already processing pre-orders. The FELIX BIOprinter expands the company’s existing portfolio of FFF…

    Read More
  • Photo of Bioprinted brain model and imaging technique helps advance tumor research

    A joint team of researchers from Rensselaer, Northwestern University and the Icahn School of Medicine at Mount Sinai has developed a methodology that could improve the treatment of aggressive glioblastoma brain tumors. The process, which combines medical imaging and bioprinting technologies, can help scientists to better understand the complex structure…

    Read More
  • Photo of WFIRM develops mini 3D organ model of the human body

    A team of scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) in North Carolina has reported the development of “the world’s most sophisticated laboratory model of the human body.” Developed using 3D bioprinting and other biofabrication techniques, the model is made up of a system of miniaturized 3D…

    Read More
  • Photo of nScrypt and taking bioprinting to the field

    The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of…

    Read More
Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*